Chronic beryllium disease: An updated model interaction between innate and acquired immunity

BioMetals

Volumn 24, Issue 1, 2011, Pages 1-17

  Sawyer, Richard T ^a   Maier, Lisa A ^b,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Food Science and Human Nutrition   (United States)

Author keywords

Acquired immunity; Beryllium; Chronic beryllium disease; Granuloma; Innate immunity

Indexed keywords

ADAPTIVE IMMUNITY; ARTICLE; BERYLLIOSIS; CHRONIC DISEASE; CHRONIC INFLAMMATION; GRANULOMA; HUMAN; HYPOTHESIS; IMMUNOPATHOGENESIS; INNATE IMMUNITY; LUNG DISEASE; NONHUMAN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL LUNG DISEASE; RISK ASSESSMENT; UNITED STATES;

ANIMALS; BERYLLIOSIS; BERYLLIUM; CHRONIC DISEASE; HUMANS; IMMUNITY, INNATE; MODELS, IMMUNOLOGICAL;

EID: 79951726885     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10534-010-9376-3     Document Type: Article

References (120)

1. M Amicosante AP Fontenot 2006 T cell recognition in chronic beryllium disease Clin Immunol 121 134 143 1:CAS:528:DC%2BD28XhtFWiur%2FM 16697706 10.1016/j.clim.2006.03.012 (Pubitemid 44572970)
2. M Amicosante N Sanarico F Berretta J Arroyo G Lombardi R Lechler V Colizzi C Saltini 2001 Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69 Hum Immunol 62 686 693 1:CAS:528:DC%2BD3MXksVymurs%3D 11423174 10.1016/S0198-8859(01)00261-0 (Pubitemid 32634936)
3. M Amicosante F Berretta A Franchi P Rogliani C Dotti M Losi R Dweik C Saltini 2002 HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells Eur Respir J 20 1174 1178 1:CAS:528:DC%2BD38XptlCmt78%3D 12449171 10.1183/09031936.02.02232001 (Pubitemid 35331875)
4. M Amicosante F Berretta R Dweik C Saltini 2009 Role of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells Immunology 128 e462 e470 19191908 10.1111/j.1365-2567.2008.03000.x
5. RL Bailey CA Thomas DC Deubner MS Kent K Kreiss CR Schuler 2010 Evaluation of a preventive program to reduce sensitization at a beryllium metal, oxide, and alloy production plant J Occup Environ Med 52 505 512 1:CAS:528:DC%2BC3cXlslCitr0%3D 20431418 10.1097/JOM.0b013e3181d6c338
6. RC Balkissoon LS Newman 1999 Beryllium copper alloy (2%) causes chronic beryllium disease J Occup Environ Med 41 304 308 1:STN:280:DyaK1M3ktFWjug%3D%3D 10224597 10.1097/00043764-199904000-00013 (Pubitemid 29190305)
7. BP Barna RA Dweik CF Farver D Culver B Yen-Lieberman MJ Thomassen 2002 Nitric oxide attenuates beryllium-induced IFN gamma responses in chronic beryllium disease: evidence for mechanisms independent of IL-18 Clin Immunol 103 169 175 1:CAS:528:DC%2BD38Xlt1SitLc%3D 12027422 10.1006/clim.2002.5211 (Pubitemid 34596985)
8. FD Batista NE Harwood 2009 The who, how and where of antigen presentation to B cells Nat Rev Immunol 9 15 27 1:CAS:528:DC%2BD1MXpt1yi 19079135 10.1038/nri2454
9. LM Bekris HM Viernes FM Farin LA Maier TJ Kavanagh TK Takaro 2006 Chronic beryllium disease and glutathione biosynthesis genes J Occup Environ Med 48 599 606 1:CAS:528:DC%2BD28XltFyhs7g%3D 16766924 10.1097/01.jom.0000201845.02369.ba (Pubitemid 43904251)
10. F Berretta RH Butler G Diaz N Sanarico J Arroyo M Fraziano G Aichinger KW Wucherpfennig V Colizzi C Saltini M Amicosante 2003 Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity Tissue Antigens 62 459 471 1:CAS:528:DC%2BD2cXkvVCn 14617029 10.1046/j.1399-0039.2003.00131.x (Pubitemid 37475994)
11. JR Bill DG Mak MT Falta LA Maier AK Sullivan FG Joslin AK Martin BM Freed BL Kotzin AP Fontenot 2005 Beryllium presentation to DC4+T cells is dependent on a single amino acid residue in the MHC class II β-chain J Immunol 175 7029 7037 1:CAS:528:DC%2BD2MXhtF2isr7J 16272364 (Pubitemid 41598950)
12. S Burgdorf A Kautz V Bohnert PA Knolle C Kurts 2007 Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation Science 316 612 616 1:CAS:528:DC%2BD2sXksFeksbk%3D 17463291 10.1126/science. 1137971 (Pubitemid 46683149)
13. KJ Butnor TA Sporn P Ingram S Gunasegaram JF Pinto VL Roggli 2003 Beryllium detection in human lung tissue using electron probe X-ray microanalysis Mod Pathol 16 1171 1177 14614058 10.1097/01.MP.0000094090.90571.ED (Pubitemid 37414213)
14. A Chaudhary NN Sauer G Gupta 2004 Beryllium-specific immune response in primary cells from healthy individuals Toxicology 201 9 19 1:CAS:528: DC%2BD2cXmsVGjsLs%3D 15297015 10.1016/j.tox.2004.03.025 (Pubitemid 39028897)
15. X Chen PE Jensen 2008 The role of B lymphocytes as antigen-presenting cells Arch Immunol Ther Exp (Warsz) 56 77 83 1:CAS:528:DC%2BD1cXmt1Cmu7k%3D 10.1007/s00005-008-0014-5 (Pubitemid 351556111)
16. TT Chen L Li DH Chung CD Allen SV Torti FM Torti JG Cyster CY Chen FM Brodsky EC Niemi MC Nakamura WE Seaman MR Daws 2005 TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis J Exp Med 202 955 965 1:CAS:528:DC%2BD2MXhtVygt7rO 16203866 10.1084/jem.20042433 (Pubitemid 41396895)
17. YK Chou DM Edwards AD Weinberg AA Vandenbark BL Kotzin AP Fontenot GG Burrows 2005 Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosis J Immunol 174 4316 4324 1:CAS:528:DC%2BD2MXisVCht78%3D 15778396 (Pubitemid 40396014)
18. SS Coates BE Lehnert S Sharma SM Kindell RK Gary 2007 Beryllium induces premature senescence in human fibroblasts J Pharmacol Exp Ther 322 70 79 1:CAS:528:DC%2BD2sXntl2jtr4%3D 17395767 10.1124/jpet.106.118018 (Pubitemid 46956349)
19. SA Comhair MJ Lewis PR Bhathena JP Hammel SC Erzurum 1999 Increased glutathione and glutathione peroxidase in lungs of individuals with chronic beryllium disease Am J Respir Crit Care Med 159 1824 1829 1:STN:280: DyaK1M3otVKgug%3D%3D 10351926 (Pubitemid 29275050)
20. KJ Cummings AB Stefaniak MA Virji K Kreiss 2009 A reconsideration of acute beryllium disease Environ Health Perspect 117 1250 1256 19672405
21. S Dai GA Murphy F Crawford DG Mack MT Falta P Marrack JW Kappler AP Fontenot 2010 Crystal structure of HLA-DP2 and implications for chronic beryllium disease Proc Natl Acad Sci 107 7425 7430 1:CAS:528: DC%2BC3cXlsFWhsLc%3D 20356827 10.1073/pnas.1001772107
22. GA Day MD Hoover AB Stefaniak RM Dickerson EJ Peterson NA Esmen RC Scripsick 2005 Bioavailability of beryllium oxide particles: an in vitro study in the murine J774A.1 macrophage cell line model Exp Lung Res 31 341 360 1:CAS:528:DC%2BD2MXitlCktbk%3D 15962713 10.1080/01902140590918731 (Pubitemid 40467604)
23. GA Day AB Stefaniak A Weston SS Tinkle 2006 Beryllium exposure: dermal and immunological considerations Int Arch Occup Environ Health 79 161 164 1:CAS:528:DC%2BD2MXht1Glsb%2FK 16231190 10.1007/s00420-005-0024-0 (Pubitemid 43008887)
24. GA Day A Dufresne AB Stefaniak CR Schuler ML Stanton WE Miller MS Kent DC Deubner K Kreiss MD Hoover 2007 Exposure pathway assessment at a copper-beryllium alloy facility Ann Occup Hyg 51 67 80 1:CAS:528: DC%2BD2sXjvV2qsLs%3D 16844720 10.1093/annhyg/mel041 (Pubitemid 46096397)
25. DR Dobis RT Sawyer MM Gillespie J Huang LS Newman LA Maier BJ Day 2008 Modulation of lymphocyte proliferation by antioxidants in chronic beryllium disease Am J Respir Crit Care Med 177 1002 1011 18218990 10.1164/rccm.200707- 1021OC (Pubitemid 351717595)
26. Dobis DR, Sawyer RT, Gillespie MM, Newman LS, Maier LA, Day BJ (2010) Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production. Am J Respir Cell Mol Biol. doi: 10.1165/rcmb.2009-0150OC
27. D Dudziak AO Kamphorst GF Heidkamp VR Bucholz C Trumpfheller S Yamazaki C Cheong K Liu HW Lee CG Park RM Steinman MC Nussenzweig 2007 Differential antigen processing by dendritic cell subsets in vivo Science 315 107 111 1:CAS:528:DC%2BD28XhtlGqtLrP 17204652 10.1126/science.1136080 (Pubitemid 46196991)
28. Everest DA (1964) The chemistry of beryllium. In: Robinson RL (ed) Topics in inorganic and general chemistry. Elsevier, Amsterdam
29. AP Fontenot BL Kotzin 2003 Chronic beryllium disease: immune-mediated destruction with implications for organ-specific autoimmunity Tissue Antigens 62 449 458 1:CAS:528:DC%2BD2cXkvVCg 14617028 10.1046/j.1399-0039.2003.00160.x (Pubitemid 37475993)
30. AP Fontenot MT Falta BM Freed LS Newman BL Kotzin 1999 Identification of pathogenic T cells in patients with beryllium-induced lung disease J Immunol 163 1019 1026 1:CAS:528:DyaK1MXksVens7o%3D 10395700 (Pubitemid 29328115)
31. AP Fontenot LS Newman BL Kotzin 2001 Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP Clin Immunol 100 4 14 1:CAS:528:DC%2BD3MXlslSnur0%3D 11414740 10.1006/clim.2001.5053 (Pubitemid 32607236)
32. + T cells in patients with chronic beryllium disease J Clin Invest 110 1473 1482 1:CAS:528:DC%2BD38XovFOmsr4%3D 12438445 (Pubitemid 35396918)
33. + T cells J Clin Invest 112 776 784 1:CAS:528:DC%2BD3sXntlSiu7o%3D 12952926 (Pubitemid 38057718)
34. + T cells in blood determines proliferative response J Clin Invest 115 2886 2893 1:CAS:528:DC%2BD2MXhtVygt7bF 16151531 10.1172/JCI24908 (Pubitemid 41434416)
35. + T cells: T cell-T cell interactions and their potential role in chronic beryllium disease Eur J Immunol 36 930 939 1:CAS:528:DC%2BD28XktVKktLw%3D 16552706 10.1002/eji.200526075
36. + T cells J Immunol 177 3874 3883 1:CAS:528:DC%2BD28XptlOgsLo%3D 16951350 (Pubitemid 44359922)
37. C Gelin I Sloma D Charron N Mooney 2009 Regulation of MHC II and CD1 antigen presentation: from ubiquity to security J Leukoc Biol 85 215 224 1:CAS:528:DC%2BD1MXhslelurw%3D 18809734 10.1189/jlb.0308206
38. CDKN1A expression and a senescence-like cell cycle arrest in susceptible cancer cell types. Biometals. doi: 10.1007/s10534-010-9352-y [ahead of print]
39. FF Hamerlinck 1999 Neopterin: a review Exp Dermatol 8 167 176 1:CAS:528:DyaK1MXjvFGltbo%3D 10389633 10.1111/j.1600-0625.1999.tb00367.x (Pubitemid 29256300)
40. J Harris BB Bartelson E Barker R Balkissoon K Kreiss LS Newman 1997 Serum neopterin in chronic beryllium disease Am J Ind Med 32 21 26 1:CAS:528:DyaK2sXjtVKhurc%3D 9131208 10.1002/(SICI)1097-0274(199707)32:1<21:: AID-AJIM3>3.0.CO;2-U (Pubitemid 27203508)
41. N Hasejima H Kobayashi S Takezawa K Yamato C Kadoyama Y Kawano 1995 Chronic beryllium disease after exposure to low-beryllium-content copper Nihon Kyobu Shikkan Gakkai Zasshi 33 1105 1110 1:STN:280:DyaK28%2Fpt1agtA%3D%3D 8544383
42. Henneberger PK, Cumro D, Duebner DD, Kent MS, McCawley M, Kreiss K (2001) Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Int Arch Occup Environ Health 74(3):167-176 (Pubitemid 32377453)
43. PK Henneberger SK Goe WE Miller B Doney DW Groce 2004 Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed J Occup Environ Hyg 1 648 659 1:CAS:528:DC%2BD2cXmsFSltbg%3D 15631056 10.1080/15459620490502233 (Pubitemid 39387567)
44. PG Holt S Haining DJ Nelson JD Sedgwick 1994 Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways J Immunol 153 256 261 1:STN:280:DyaK2c3mslagsw%3D%3D 8207240 (Pubitemid 24186538)
45. E Hong-Geller 2009 A role for cell adhesion in beryllium-mediated lung disease J Occup Environ Hyg 6 727 731 1:CAS:528:DC%2BD1MXhtlyqtrjK 19894172 10.1080/15459620903011160
46. E Hong-Geller PE Pardington RB Cary NN Sauer G Gupta 2006 Chemokine regulation in response to beryllium exposure in human peripheral blood mononuclear and dendritic cells Toxicology 218 216 228 1:CAS:528: DC%2BD2MXhtlGitrjI 16314022 10.1016/j.tox.2005.10.016 (Pubitemid 41821352)
47. DA Hume 2008 Macrophages as APC and the dendritic cell myth J Immunol 181 5829 5835 1:CAS:528:DC%2BD1cXht1Krtr3M 18941170
48. PF Infante LS Newman 2004 Beryllium exposure and chronic beryllium disease Lancet 363 415 416 14962519 10.1016/S0140-6736(04)15523-2 (Pubitemid 38210056)
49. AC Jonth L Silveira TE Fingerlin H Sato JC Luby KI Welsh CS Rose LS Newman RM du Bois LA Maier 2007 TGF-beta 1 variants in chronic beryllium disease and sarcoidosis J Immunol 179 4255 4262 1:CAS:528:DC%2BD2sXpvFKlurs%3D 17785866
50. TS Keizer NN Sauer TM McCleskey 2005 Beryllium binding at neutral pH: the importance of the Be-O-Be motif J Inorg Biochem 99 1174 1181 1:CAS:528:DC%2BD2MXjtFyrsL4%3D 15833341 10.1016/j.jinorgbio.2005.02.017
51. LA Kittle RT Sawyer VA Fadok LA Maier LS Newman 2002 Beryllium induces apoptosis in human lung macrophages Sarcoidosis Vasc Diffuse Lung Dis 19 101 113 12102605 (Pubitemid 34685909)
52. N Kokturk M Sabag M Stark J Grief E Fireman 2009 High extracellular induced sputum haem oxygenase-1 in sarcoidosis and chronic beryllium disease Eur J Clin Invest 39 584 590 1:CAS:528:DC%2BD1MXovVCisb8%3D 19453654 10.1111/j.1365-2362.2009.02137.x
53. D Kreisel AS Krupnick KR Balsara M Riha AE Gelman SH Popma WY Szeto LA Turka BR Rosengard 2002 Mouse vascular endothelium activates CD8+T lymphocytes in a B7-dependent fashion J Immunol 169 6154 6161 1:CAS:528:DC%2BD38Xpt1Kmurw%3D 12444119 (Pubitemid 36903460)
54. L Li CJ Fang JC Ryan EC Niemi JA Lebron PJ Bjorkman H Arase FM Torti SV Torti MC Nakamura WE Seaman 2010 Binding and uptake of H-ferritin are mediated by human transferrin receptor-1 Proc Natl Acad Sci 107 3505 3510 1:CAS:528:DC%2BC3cXjtFOls7g%3D 20133674 10.1073/pnas.0913192107
55. AH Limper TV Colby MS Sanders S Asakura PC Roche RA DeRemee 1994 Immunohistochemical localization of transforming growth factor-beta 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis Am J Respir Crit Care Med 149 197 204 1:STN:280:DyaK2c7lsV2rsg%3D%3D 8111583 (Pubitemid 24066120)
56. DG Mack AK Lanham BE Palmer LA Maier TH Watts AP Fontenot 2008 4-1BB enhances proliferation of beryllium-specific T cells in the lung of subjects with chronic beryllium disease J Immunol 181 4381 4388 1:CAS:528: DC%2BD1cXhtVKntbfO 18768897
57. + T cells differentiates effector from regulatory T cell subsets in the lung J Immunol 182 7317 7324 1:CAS:528:DC%2BD1MXmtVKqu7s%3D 19454729 10.4049/jimmunol.0804305
58. DG Mack AM Lanham MT Falta BE Palmer LA Maier AP Fontenot 2010 Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects Am J Respir Crit Care Med 181 1241 1249 1:CAS:528:DC%2BC3cXhtFOhsrfN 20299529 10.1164/rccm.201001-0025OC
59. LA Maier RT Sawyer RA Bauer LA Kittle P Lympany D McGrath R Dubois E Daniloff CS Rose LS Newman 2001 High beryllium-stimulated TNF-alpha is associated with the -308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease Am J Respir Crit Care Med 164 1192 1199 1:STN:280:DC%2BD3MnnsVSrsA%3D%3D 11673208 (Pubitemid 33052249)
60. LA Maier RT Sawyer SS Tinkle LA Kittle EA Barker R Balkissoon C Rose LS Newman 2001 IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis Eur Respir J 17 403 415 1:CAS:528:DC%2BD3MXkslGrsL0%3D 11405518 10.1183/09031936.01.17304030 (Pubitemid 32600608)
61. LA Maier LA Kittle MM Mroz LS Newman 2003 Beryllium-stimulated neopterin as a diagnostic adjunct in chronic beryllium disease Am J Ind Med 43 592 601 1:CAS:528:DC%2BD3sXkvFOgsbc%3D 12768609 10.1002/ajim.10227 (Pubitemid 36618349)
62. LA Maier DS McGrath H Sato P Lympany K Welsh R Du Bois L Silveira AP Fontenot RT Sawyer E Wilcox LS Newman 2003 Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease J Immunol 171 6910 6918 1:CAS:528:DC%2BD3sXpsV2rurs%3D 14662898 (Pubitemid 37532127)
63. J Marchal-Somme Y Uzunhan S Marchand-Adam M Kambouchner D Valeyre B Crestani P Soler 2007 Dendritic cells accumulate in human fibrotic interstitial lung disease Am J Respir Crit Care Med 176 1007 1014 17717200 10.1164/rccm.200609-1347OC (Pubitemid 350127845)
64. S Marchand-Adam A El Khatib F Guillon MW Brauner C Lamberto V Lepage JM Naccache D Valeyre 2008 Short- and long-term response to corticosteroid therapy in chronic beryllium disease Eur Respir J 32 687 693 1:CAS:528: DC%2BD1cXht1enurzP 18757698 10.1183/09031936.00149607
65. EC McCanlies JS Ensey CR Schuler K Kreiss A Weston 2004 The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization Am J Ind Med 46 95 103 1:CAS:528:DC%2BD2cXntVyru7k%3D 15273960 10.1002/ajim.20045 (Pubitemid 39062615)
66. EC McCanlies CR Schuler K Kreiss BL Frye JS Ensey A Weston 2007 TNF-alpha polymorphisms in chronic beryllium disease and beryllium sensitization J Occup Environ Med 49 446 452 1:CAS:528:DC%2BD2sXjslWjtbc%3D 17426528 10.1097/JOM.0b013e31803b9499 (Pubitemid 46624362)
67. TM McCleskey V Buchner RW Field BL Scott 2009 Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review Rev Environ Health 24 75 115 1:CAS:528:DC%2BD1MXhtFait7vK 19658317
68. LW McKeehan 1922 The crystal structure of beryllium and of beryllium oxide Proc Natl Acad Sci USA 8 270 274 1:CAS:528:DyaB3sXns12l 16586895 10.1073/pnas.8.9.270
69. J Mestas CC Hughes 2001 Endothelial cell costimulation of T cell activation through CD58-CD2 interactions involves lipid raft aggregation J Immunol 167 4378 4385 1:CAS:528:DC%2BD3MXns1GmtbY%3D 11591762 (Pubitemid 32954314)
70. MM Mroz K Kreiss DC Lezotte PA Campbell LS Newman 1991 Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease J Allergy Clin Immunol 88 54 60 1:STN:280:DyaK3Mzgt1Kntw%3D%3D 2071785 10.1016/0091-6749(91)90300-D
71. MM Mroz LA Maier M Strand L Silviera LS Newman 2009 Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease Am J Ind Med 52 762 773 1:CAS:528:DC%2BD1MXht1Oit7zO 19681064 10.1002/ajim.20736
72. LS Newman MM Mroz R Balkissoon LA Maier 2005 Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk Am J Respir Crit Care Med 171 54 60 15374840 10.1164/rccm.200402-190OC (Pubitemid 40051695)
73. AM Nilsen R Vik C Behrens PA Drablos T Espevik 2010 Beryllium sensitivity among workers at a Norwegian aluminum smelter Am J Ind Med 53 724 732 1:CAS:528:DC%2BC3cXpt1OmtLk%3D 20187010
74. BE Palmer DG Mack AK Martin LA Maier AP Fontenot 2007 CD57 expression correlates with alveolitis severity in subjects with beryllium-induced disease J Allergy Clin Immunol 120 184 191 1:CAS:528:DC%2BD2sXntF2ms74%3D 17416406 10.1016/j.jaci.2007.03.009 (Pubitemid 46990484)
75. BE Palmer DG Mack AK Martin MM Gillespie MM Mroz LA Maier AP Fontenot 2008 Up-regulation of programmed death-1 expression on beryllium-specific CD4+T cell sin chronic beryllium disease J Immunol 180 2704 2712 1:CAS:528: DC%2BD1cXhsVSgsLY%3D 18250483
76. GP Pappas LS Newman 1993 Early pulmonary physiologic abnormalities in beryllium disease Am Rev Respir Dis 148 661 666 1:STN:280:DyaK3sznvVajsw%3D%3D 8368637 (Pubitemid 23263776)
77. + T cell interactions promote T(H)2 cytokine-dependent immunity Nat Immunol 10 697 705 1:CAS:528: DC%2BD1MXmtlarsLs%3D 19465906 10.1038/ni.1740
78. + T cells in patients with beryllium-induced disease J Allergy Clin Immunol 115 1036 1042 1:CAS:528:DC%2BD2MXjslKisrg%3D 15867863 10.1016/j.jaci.2005.01.019 (Pubitemid 40616220)
79. DJ Price JG Joshi 1983 Ferritin: binding of beryllium and other divalent metal ions J Biol Chem 258 10873 10880 1:CAS:528:DyaL3sXlsFCjur0%3D 6411722
80. P Reichardt B Dornbach S Rong S Beissert F Gueler K Loser M Gunzer 2007 Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse Blood 110 1519 1529 1:CAS:528:DC%2BD2sXhtVSgsb3J 17392507 10.1182/blood-2006-10-053793 (Pubitemid 47443968)
81. MD Rossman 2001 Chronic beryllium disease: a hypersensitivity disorder Appl Occup Environ Hyg 16 615 618 1:CAS:528:DC%2BD3MXktFKgs7k%3D 11370939 10.1080/10473220121477 (Pubitemid 32428743)
82. MD Rossman JA Kern JA Elias MR Cullen PE Epstein OP Preuss TN Markham RP Daniele 1988 Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease Ann Intern Med 108 687 693 1:STN:280:DyaL1c7pt1Wgtw%3D%3D 3282464
83. MD Rossman J Stubbs CW Lee E Argyris E Magira D Monos 2002 Human leukocyte antigen class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity Am J Respir Crit Care Med 165 788 794 11897645 (Pubitemid 34229648)
84. M Rouleau C Dion P Plamondon G Kennedy G L'Esperance J Zayed 2005 Physical and chemical characterization of beryllium particles from several workplaces in Quebec, Canada-part A: determining methods for the analysis of low levels of beryllium J Toxicol Environ Health A 68 1889 1905 1:CAS:528:DC%2BD2MXhtV2htL%2FP 16207636 10.1080/15287390500246365 (Pubitemid 41783263)
85. BA Rybicki JL Walewski MJ Maliarik H Kian MC Iannuzzi 2005 The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites Am J Hum Genet 77 491 499 1:CAS:528:DC%2BD2MXpsFCrsr0%3D 16080124 10.1086/444435 (Pubitemid 41192655)
86. HM Sackett LA Maier LJ Silveira MM Mroz LG Ogden JR Murphy LS Newman 2004 Beryllium medical surveillance at a former nuclear weapons facility during cleanup operations J Occup Environ Med 46 953 961 1:CAS:528:DC%2BD2cXntFCmu7g%3D 15354061 10.1097/01.jom.0000139872.80118.bd (Pubitemid 39237556)
87. F Salehi J Zayed S Audusseau C Muller G Truchon P Plamondon G L'Esperance G Chevalier B Mazer 2009 Immunological responses in C3H/HeJ mice following nose-only inhalation exposure to different sizes of beryllium metal particles J Appl Toxicol 29 61 68 1:CAS:528:DC%2BD1MXptV2qug%3D%3D 18980269 10.1002/jat.1383
88. G Samuel LA Maier 2008 Immunology of chronic beryllium disease Curr Opin Allergy Clin Immunol 8 126 134 1:CAS:528:DC%2BD1cXjvF2jtrw%3D 18317020 10.1097/ACI.0b013e3282f824a4 (Pubitemid 351654307)
89. H Sato L Silveira T Fingerlin K Dockstader M Gillespie AL Lagan P Lympany RT Sawyer RM du Bois KI Welsh LA Maier 2007 TNF polymorphism and bronchoalveolar lavage cell TNF-alpha levels in chronic beryllium disease and beryllium sensitization J Allergy Clin Immunol 119 687 696 1:CAS:528: DC%2BD2sXisVWjsLs%3D 17208287 10.1016/j.jaci.2006.10.028
90. H Sato P Spagnolo L Silveira KI Welsh RM du Bois LS Newman LA Maier 2007 BTNL2 allele associations with chronic beryllium disease in HLA- DPB1*Glu69-negative individuals Tissue Antigens 70 480 486 1:CAS:528:DC%2BD1cXitF2gtQ%3D%3D 17927685 10.1111/j.1399-0039.2007.00944.x (Pubitemid 350075795)
91. RT Sawyer VA Fadok LA Kittle LA Maier LS Newman 2000 Beryllium-stimulated apoptosis in macrophage cell lines Toxicology 149 129 142 1:CAS:528: DC%2BD3cXmtVCktro%3D 10967410 10.1016/S0300-483X(00)00237-7 (Pubitemid 30628321)
92. RT Sawyer LA Maier LA Kittle LS Newman 2002 Chronic beryllium disease: a model interaction between innate and acquired immunity Int Immunopharmacol 2 249 261 1:CAS:528:DC%2BD38Xos1SksQ%3D%3D 11811929 10.1016/S1567-5769(01)00177-1 (Pubitemid 34075415)
93. RT Sawyer BJ Day VA Fadok M Chiarappa-Zucca LA Maier AP Fontenot L Silveira LS Newman 2004 Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease Am J Respir Cell Mol Biol 31 470 477 1:CAS:528:DC%2BD2cXot12ntb0%3D 15256386 10.1165/rcmb.2004-0090OC (Pubitemid 39330958)
94. + T cells is mediated by HLA-DP Am J Respir Cell Mol Biol 31 122 130 1:CAS:528:DC%2BD2cXlsFKjsbc%3D 14975942 10.1165/rcmb.2003-0336OC (Pubitemid 38888048)
95. RT Sawyer JL Abraham E Daniloff LS Newman 2005 Secondary ion mass spectroscopy demonstrates retention of beryllium in chronic beryllium disease granulomas J Occup Environ Med 47 1218 1226 1:CAS:528:DC%2BD2MXht1Oks7bM 16340702 10.1097/01.jom.0000184884.85325.36 (Pubitemid 41813029)
96. RT Sawyer DR Dobis M Goldstein L Velsor LA Maier AP Fontenot L Silveira LS Newman BJ Day 2005 Beryllium-stimulated reactive oxygen species and macrophage apoptosis Free Radic Biol Med 38 928 937 1:CAS:528: DC%2BD2MXitVCnsLc%3D 15749389 10.1016/j.freeradbiomed.2004.12.014 (Pubitemid 40321085)
97. RT Sawyer AP Fontenot TA Barnes CE Parsons BC Tooker LA Maier MM Gillespie EB Gottschall L Silveira J Hagman LS Newman 2007 Beryllium-induced TNF-alpha production is transcription-dependent in chronic beryllium disease Am J Respir Cell Mol Biol 36 191 200 1:CAS:528:DC%2BD2sXhvFWjurg%3D 16980557 10.1165/rcmb.2006-0021TR (Pubitemid 46233472)
98. MA Schon-Hegrad J Oliver PG McMenamin PG Holt 1991 Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the conducting airways J Exp Med 173 1345 1356 1:STN:280:DyaK3M3jslarsA%3D%3D 2033368 10.1084/jem.173.6.1345
99. BL Scott Z Wang BL Marrone NN Sauer 2003 Potential binding modes of beryllium with the class II major histocompatibility complex HLA-DP: a combined theoretical and structural database study J Inorg Biochem 94 5 13 1:CAS:528:DC%2BD3sXhs1Kls7w%3D 12620668 10.1016/S0162-0134(02)00628-1 (Pubitemid 36297043)
100. K Shortman YJ Liu 2002 Mouse and human dendritic cell subtypes Nat Rev Immunol 2 151 161 1:CAS:528:DC%2BD38XisFaktLc%3D 11913066 10.1038/nri746 (Pubitemid 37336516)
101. K Shortman SH Naik 2007 Steady-state and inflammatory dendritic-cell development Nat Rev Immunol 7 19 30 1:CAS:528:DC%2BD28XhtlCht7fF 17170756 10.1038/nri1996 (Pubitemid 46020824)
102. S Silva K Ganguly TM Fresquez G Gupta TM McCleskey A Chaudhary 2009 Beryllium alters lipopolysaccharide-mediated intracellular phosphorylation and cytokine release in human peripheral blood mononuclear cells J Occup Environ Hyg 6 775 782 1:CAS:528:DC%2BD1MXhtlyqtrbE 19894180 10.1080/15459620903267986
103. + T cells to lung and subsequent pulmonary fibrosis J Immunol 177 4436 4443 1:CAS:528: DC%2BD28Xps1Ggtb0%3D 16982878 (Pubitemid 44469772)
104. PL Simonian CL Roark F Wehrmann AK Lanham F Diaz del Valle WK Born RL O'Brien AP Fontenot 2009 Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis J Immunol 182 657 665 1:CAS:528:DC%2BD1MXltlymt7o%3D 19109199 10.4049/jimmunol.0900013
105. JA Snyder A Weston SS Tinkle E Demchuk 2003 Electrostatic potential on human leukocyte antigen: implications for putative mechanism of chronic beryllium disease Environ Health Perspect 111 1827 1834 1:CAS:528: DC%2BD3sXhtVSqsb7E 14630515 10.1289/ehp.6327 (Pubitemid 37526963)
106. CL Sokol NQ Chu S Yu SA Nish TM Laufer R Medzhitov 2009 Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response Nat Immunol 10 713 720 1:CAS:528:DC%2BD1MXmtlaku7g%3D 19465907 10.1038/ni.1738
107. AB Stefaniak RA Guilmette GA Day MD Hoover PN Breysse RC Scripsick 2005 Characterization of phagolysosomal simulant fluid for study of beryllium aerosol particle dissolution Toxicol In Vitro 19 123 134 1:CAS:528:DC%2BD2cXhtVCgt7jP 15582363 10.1016/j.tiv.2004.08.001 (Pubitemid 39592984)
108. OA Taiwo MD Slade LF Cantley MG Fiellin JC Wesdock FJ Bayer MR Cullen 2008 Beryllium sensitization in aluminum smelter workers J Occup Environ Med 50 157 162 1:CAS:528:DC%2BD1cXhsVyiu7c%3D 18301172 10.1097/JOM.0b013e318161783f (Pubitemid 351321683)
109. Taiwo OA, Slade MD, Cantley LF, Kirsche SR, Wesdock JC, Cullen MR (2010) Prevalence of beryllium sensitization among aluminum smelter workers. Occup Med. doi: 10.1093/occmed/kqq097 [ahead of print]
110. LM Tarantino-Hutchison C Sorrentino A Nadas Y Zhu EM Rubin SS Tinkle A Weston T Gordon 2009 Genetic determinants of sensitivity to beryllium in mice J Immunotoxicol 6 130 135 1:CAS:528:DC%2BD1MXhtVGit7bK 19589099 10.1080/15476910902977399
111. SS Tinkle LS Newman 1997 Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease Am J Respir Crit Care Med 156 1884 1891 1:STN:280:DyaK1c%2FnsVSntA%3D%3D 9412570 (Pubitemid 28011797)
112. SS Tinkle LA Kittle BA Schumacher LS Newman 1997 Beryllium induces IL-2 and IFN-gamma in berylliosis J Immunol 158 518 526 1:CAS:528: DyaK2sXhsVemug%3D%3D 8977230 (Pubitemid 127483896)
113. SS Tinkle LA Kittle LS Newman 1999 Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease J Immunol 163 2747 2753 1:CAS:528:DyaK1MXls1Kru7w%3D 10453017 (Pubitemid 29399201)
114. SS Tinkle JM Antonini BA Rich JR Roberts R Salmen K DePree EJ Adkins 2003 Skin as a route of exposure and sensitization in chronic beryllium disease Environ Health Perspect 111 1202 1208 1:CAS:528:DC%2BD3sXmsVektb4%3D 12842774 10.1289/ehp.5999 (Pubitemid 36939402)
115. HB Wang I Ghiran K Matthaei PF Weller 2007 Airway eosinophils: allergic inflammation recruited professional antigen-presenting cells J Immunol 179 7585 7592 1:CAS:528:DC%2BD2sXhtlajt7rJ 18025204
116. PA Wearsch P Cresswell 2008 The quality control of MHC class I peptide loading Curr Opin Cell Biol 20 624 631 1:CAS:528:DC%2BD1cXhsVKrur3F 18926908 10.1016/j.ceb.2008.09.005
117. L Welch K Ringen E Bingham J Dement T Takaro W McGowan A Chen P Quinn 2004 Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites Am J Ind Med 46 207 218 1:CAS:528: DC%2BD2cXot1alsr8%3D 15307119 10.1002/ajim.20059 (Pubitemid 39180816)
118. 2 accumulation for cell signaling Cell 140 517 528 1:CAS:528:DC%2BC3cXlt1Klt7w%3D 20178744 10.1016/j.cell.2010.01.009
119. B Yazdanpanah K Wiegmann V Tchikov O Krut C Pongratz M Schramm A Kleinridders T Wunderlich H Kashkar O Utermohlen JC Bruning S Schutze M Kronke 2009 Riboflavin kinase couples TNF receptor 1 to NADPH oxidase Nature 460 1159 1163 1:CAS:528:DC%2BD1MXpt1Wgur0%3D 19641494 10.1038/nature08206
120. + T cells Nat Immunol 10 706 712 1:CAS:528:DC%2BD1MXmtlakurY%3D 19465908 10.1038/ni.1737